Primary prevention with the ICD in clinical practice: not as straightforward as the guidelines suggest?

Area of Science:

• Cardiology
• Medical Devices
• Preventive Medicine

Background:

• Implantable cardioverter defibrillators (ICDs) are used for primary prevention of sudden cardiac death (SCD) in patients with left ventricular systolic dysfunction.
• Current guidelines appear straightforward, with defined cut-off values for ejection fraction and functional class.

Purpose of the Study:

• To critically evaluate the apparent simplicity of ICD implantation guidelines for primary SCD prevention.
• To identify ambiguities and limitations in current decision-making criteria for ICD therapy.

Main Methods:

• Review of existing guidelines for ICD implantation.
• Analysis of factors influencing the accuracy of ejection fraction determination.
• Consideration of additional risk factors for SCD not included in current guidelines.
• Evaluation of the impact of patient longevity on the expected benefit of ICD therapy.

Main Results:

• Ejection fraction determination is not always unambiguous, introducing variability in risk assessment.
• Key risk factors for SCD are often overlooked in current decision-making protocols.
• Patient longevity significantly affects the clinical utility of ICDs, potentially limiting benefits in the elderly and underestimating them in younger individuals.

Conclusions:

• Current guidelines for ICD implantation in primary SCD prevention require refinement.
• A more comprehensive risk assessment, including factors beyond ejection fraction and considering patient longevity, is necessary for optimal patient selection.
• Further research is needed to incorporate these factors into revised clinical guidelines.